ZBIO Zenas BioPharma, Inc.
Healthcare$18.73-1.27%ClosedMarket Cap: $836.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.14
P/S
0.00
EV/EBITDA
-1.69
DCF Value
$-0.29
FCF Yield
-24.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-167.7%
ROA
-56.9%
ROIC
-61.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-77.3M | $-81.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-238.0M | $-240.4M | $— | — |
| FY null | $10.0M | 100.0% | $-211.4M | $-377.7M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-52.6M | $-51.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-55.2M | $-52.2M | $— | — |
| Q1 null | $10.0M | 100.0% | $-37.3M | $-33.6M | $— | — |
| Q4 null | $5.0M | 100.0% | $-55.6M | $-52.6M | $— | — |
| FY null | $5.0M | -2682.8% | $-163.9M | $-157.0M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-41.0M | $-38.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-39.7M | $-38.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-27.6M | $-27.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-24.8M | $-24.6M | $-0.64 | — |